Navigate the NGS
universe with confidence
The varvis® software is your cloud-based, IVDR-certified solution for clinical NGS - supporting both short- and long-read sequencing across all key applications, including panels, exomes, genomes, cancer diagnostics, and carrier screening
One software solution for all NGS Use Cases
Each NGS application has its own challenges and requirements, tiny gears that have to work together perfectly.
The varvis® software is a unified platform that integrates raw data processing, genomic data management, and variant interpretation into one seamless workflow. Its intuitive user interface, combined with powerful filtering and real-time quality control enables efficient classification and reporting of SNVs, CNVs, STRs, and SVs. With pipelines of proven performance and expert onboarding support, the varvis® software accelerates your diagnostic process and reduces operational burden
See for yourself how the varvis® software can accelerate your laboratory workflows
and increase your diagnostic yield.
Read more
Can long-read sequencing replace array diagnostics in clinical routine?
by Dr. Ben Liesfeld, June 18, 2026
This white paper highlights how long-read sequencing is emerging as a strong alternative to array-based diagnostics in clinical genomics. It also explains how combining structural variant (SV) calling with coverage-based CNV analysis enables comprehensive detection across variant types, and how the varvis® platform brings these capabilities together in a unified long-read workflow.
Huntington’s disease: from understanding repeat instability to editing the genetic code
by Dr. Roberta Trunzo, April 14, 2026
Huntington’s disease (HD) has long been known as a genetic disorder caused by CAG repeat expansions in the HTT gene. Yet for decades, one key question remained unanswered: Why does the mutation remain silent for years, only to trigger neurodegeneration later in life? Recent discoveries have reshaped our understanding — and, for the first time, offered a way to intervene at the genetic level.
Elena is unstoppable
by Ulrike Schmidt, February 27, 2026
Each year, Rare Disease Day offers the human genetics community a special opportunity to raise awareness of rare diseases and the people living with them. This year, we would like to introduce you to Elena Semechin, a two-time Paralympic winner, and our partnership.